Teligent, Inc. Announces Transition in Leadership
BUENA, N.J., Feb. 05, 2020 (GLOBE NEWSWIRE) — Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey based […]
Uniti Group Inc. Announces Launch of Senior Secured Notes Offering
LITTLE ROCK, Ark., Feb. 05, 2020 (GLOBE NEWSWIRE) — Uniti Group Inc. (the “Company”, “Uniti”, or “we”) (Nasdaq: UNIT) today […]
Isoray Collaborates with MIM Software to Deliver an Advanced Treatment Solution for Recurrent Head and Neck Cancers
RICHLAND, WASH., Feb. 05, 2020 (GLOBE NEWSWIRE) — Isoray, Inc. (NYSE American: ISR) today announced an executed agreement with MIM […]
Relevium Announces Update Call for Shareholders
MONTREAL, Feb. 05, 2020 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or […]
Revive Therapeutics Announces Offering of $210,000 of Convertible Debenture Units
TORONTO, Feb. 05, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive”), a cannabis life sciences company focused on novel cannabinoid-based […]
CHF Solutions Receives CE Mark for its New Aquadex SmartFlow™ Console
EDEN PRAIRIE, Minn., Feb. 05, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced the receipt of a CE […]
Tuesday Morning Corporation Announces Second Quarter Fiscal 2020 Results
• Net sales were $324.4 million in Q2 fiscal 2020• Comparable store sales decreased 3.0% versus a 1.9% increase in the […]
HTG EdgeSeq miRNA Whole Transcriptome Assay is Highly Reproducible in Biofluids for Potential Use as a Biomarker
TUCSON, Ariz., Feb. 05, 2020 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose […]
Akerna Inks Deal with PAX Labs
DENVER, Feb. 05, 2020 (GLOBE NEWSWIRE) — Akerna (Nasdaq: KERN), a global regulatory compliance technology company in the cannabis space, […]
Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development
CAMBRIDGE, Mass., Feb. 05, 2020 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, [...]
